Xencor, Inc. announced the appointment of Bart Cornelissen to senior vice president and chief financial officer. Mr
Company Information
Company
Xencor
Location
Pasadena, California, United States
About
Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of patients with cancer and other serious diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com.